These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 22378151)

  • 1. Role of fibroblast growth factor 2 and Wnt signaling in anabolic effects of parathyroid hormone on bone formation.
    Fei Y; Hurley MM
    J Cell Physiol; 2012 Nov; 227(11):3539-45. PubMed ID: 22378151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
    Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impaired bone anabolic effect of PTH in the absence of endogenous FGF2 is partially due to reduced ATF4 expression.
    Fei Y; Xiao L; Hurley MM
    Biochem Biophys Res Commun; 2011 Aug; 412(1):160-4. PubMed ID: 21806973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Parathyroid hormone and Wnt signaling].
    Tamura Y; Kaji H
    Clin Calcium; 2013 Jun; 23(6):847-52. PubMed ID: 23719497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormones and osteoporosis update. Mechanisms of anabolic and catabolic effects of PTH on bone].
    Kobayashi T
    Clin Calcium; 2009 Jul; 19(7):911-8. PubMed ID: 19567985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P; Aarnisalo P; Chubb R; Poulton IJ; Guo J; Nachtrab G; Kimura T; Swami S; Saeed H; Chen M; Weinstein LS; Schipani E; Sims NA; Kronenberg HM; Wu JY
    J Biol Chem; 2016 Jan; 291(4):1631-1642. PubMed ID: 26598522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous FGF-2 is critically important in PTH anabolic effects on bone.
    Sabbieti MG; Agas D; Xiao L; Marchetti L; Coffin JD; Doetschman T; Hurley MM
    J Cell Physiol; 2009 Apr; 219(1):143-51. PubMed ID: 19107841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGF2 crosstalk with Wnt signaling in mediating the anabolic action of PTH on bone formation.
    Xiao L; Fei Y; Hurley MM
    Bone Rep; 2018 Dec; 9():136-144. PubMed ID: 30258857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytokines in bone diseases. Bone anabolic action of PTH and role of cytokine].
    Kaji H; Sugimoto T
    Clin Calcium; 2010 Oct; 20(10):1555-61. PubMed ID: 20890039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.
    Marie PJ; Kassem M
    Eur J Endocrinol; 2011 Jul; 165(1):1-10. PubMed ID: 21543379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult-Onset Deletion of β-Catenin in (10kb)Dmp1-Expressing Cells Prevents Intermittent PTH-Induced Bone Gain.
    Kedlaya R; Kang KS; Hong JM; Bettagere V; Lim KE; Horan D; Divieti-Pajevic P; Robling AG
    Endocrinology; 2016 Aug; 157(8):3047-57. PubMed ID: 27253995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition.
    Witcher PC; Miner SE; Horan DJ; Bullock WA; Lim KE; Kang KS; Adaniya AL; Ross RD; Loots GG; Robling AG
    JCI Insight; 2018 Jun; 3(11):. PubMed ID: 29875318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of parathyroid hormone on osteogenesis is mediated partly by osteolectin.
    Zhang J; Cohen A; Shen B; Du L; Tasdogan A; Zhao Z; Shane EJ; Morrison SJ
    Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34140410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans.
    Aslan D; Andersen MD; Gede LB; de Franca TK; Jørgensen SR; Schwarz P; Jørgensen NR
    Scand J Clin Lab Invest; 2012 Feb; 72(1):14-22. PubMed ID: 22085136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis.
    Canalis E
    Eur J Endocrinol; 2018 Feb; 178(2):R33-R44. PubMed ID: 29113980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin.
    Bonnet N; Conway SJ; Ferrari SL
    Proc Natl Acad Sci U S A; 2012 Sep; 109(37):15048-53. PubMed ID: 22927401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of paraoxonase-1 in bone anabolic effects of parathyroid hormone in hyperlipidemic mice.
    Lu J; Cheng H; Atti E; Shih DM; Demer LL; Tintut Y
    Biochem Biophys Res Commun; 2013 Feb; 431(1):19-24. PubMed ID: 23291186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphiregulin lacks an essential role for the bone anabolic action of parathyroid hormone.
    Jay FF; Vaidya M; Porada SM; Andrukhova O; Schneider MR; Erben RG
    Mol Cell Endocrinol; 2015 Dec; 417():158-65. PubMed ID: 26427650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
    Bodine PV; Seestaller-Wehr L; Kharode YP; Bex FJ; Komm BS
    J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.